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Report of a Study on IMRT Planning Strategies for 
Ethmoid Sinus Cancer 
Filip Claus1, Ben Mijnheer2, Coen Rasch2, Thomas Bortfeld3, Benedick Fraass4, Werner De Gersem1, 
Holger Wirtz5, Cordelia Hoinkis6, Byung Chul Cho7, Lai Wan Dora Kwong8, Hoonsik Bae7, Karin Muller9,
Wilfried De Neve1
Aim: This communication reviews the planning strategies and dose statistics of nine IMRT plans generated for a complex head
and neck case. 
Patient and Method: An ethmoid sinus cancer case was sent as an IMRT planning task to all participants of the ESTRO course on
“IMRT and Other Conformal Techniques in Practice”, held in Amsterdam in June 2001. 
Results: Nine IMRT plans were generated for the case, the majority of the plans generated with commercial planning systems. The
number of beam incidences ranged between four and eleven, while five of the nine beam setups were coplanar. The planning tar-
get volume dose homogeneity was inversely correlated with the degree of sparing of the surrounding organs at risk. 
Conclusion: IMRT strategies for complex head and neck cases, such as ethmoid sinus cancer, can be strikingly different in vari-
ous aspects, such as beam setup, total number of segments, PTV dose coverage and dose statistics for organs at risks. 
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Bericht über eine Studie über IMRT-Planungsstrategien für einen Nasennebenhöhlentumor  
Ziel: Diese Kurzmitteilung beschreibt und vergleicht die Planungsstrategien und Dosisstatistiken von neun IMRT-Plänen für einen
Nasennebenhöhlentumor. 
Patient und Methode: Die Planung einer intensitätsmodulierten Strahlenbehandlung (IMRT) für einen Nasennebenhöhlentumor
im Siebbein wurde den Teilnehmern des ESTRO-Kurses „IMRT and Other Conformal Techniques in Practice“ in Amsterdam im Juni
2001 als Aufgabe gestellt. 
Ergebnisse: Für den vorgegebenen Fall wurden neun intensitätsmodulierte Bestrahlungspläne erstellt, die Mehrzahl unter Ver-
wendung kommerzieller Bestrahlungsplanungssysteme. Die Zahl der Einstrahlrichtungen variierte zwischen vier und elf, fünf der
neun Strategien verwendeten ausschließlich koplanare Einstrahlrichtungen. Die Homogenität der Dosisverteilung im Planungs-
zielvolumen korrelierte invers mit dem Schonungsgrad der umliegenden Risikostrukturen. 
Schlussfolgerung: IMRT-Planungsstrategien für komplexe HNO-Fälle, wie beispielsweise Nasennebenhöhlentumoren, weisen für
eine Vielzahl von Aspekten, wie Zusammenstellung der Felder, Gesamtzahl der Segmente, Homogenität der Dosisdeposition im
Planungszielvolumen oder Dosisstatistik der Risikostrukturen, auffallende Unterschiede auf. 
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Introduction 
In June 2001, 165 participants attended the annual ESTRO
course on “IMRT and Other Conformal Techniques in Prac-
tice” in Amsterdam. An important aspect of the meeting was
the discussion of clinical cases. These cases were sent 2 months
before the course to all participants and had to be prepared
preferably by a team consisting of a radiation oncologist, a
physicist and a dosimetrist (radiation technologist). Several
aspects, both clinical and physical, were then discussed during
the course. 
This year, an IMRT planning case for ethmoid sinus can-
cer was sent to all participants registered for the course, to the
members of the teaching staff and to all participating treat-
ment planning companies. The main goal of the planning ex-
ercise was to get an impression of the current availability of
IMRT planning platforms in different institutions and of the
various IMRT strategies used to plan this case. This manu-
script reviews the characteristics of nine IMRT plans generat-
ed for this case.
Patients and Methods 
Case Description 
A 60-year-old carpenter was diagnosed in November 2000
with a cT2cN0M0 adenocarcinoma of the right ethmoid sinus
cells. After surgical resection of the lesion, the man was re-
ferred for a postoperative irradiation. 
The patient underwent a CT scan (Siemens Somatom) in
supine position from the vertex to the sternoclavicular junc-
tion. Adjacent 2 mm thick slices were generated for a region
that widely covered the paranasal sinuses, and adjacent 5 mm
thick slices outside this region. The dataset consisted of 89
transverse slices, with a pixel resolution of 512  512. The
pixel size was 0.98 mm and the pixel values ranged between
-1,024 and 3,071 Hounsfield units. The dataset file format was
DICOM and for ADAC users, the Pinnacle specific image
dataset file format was also available.
The CTV was defined up-front (imprinted in the CT
dataset), just as for the optic nerves and the optic chiasm, of
which the exact locations were determined by the use of MRI
(image co-registration). For the spinal cord, the brainstem
and other organs at risk, no contours were imprinted in the
CT dataset. Figures 1a to 1c show the location of the CTV, the
optic nerves and the optic chiasm. 
Treatment Plan Objectives and Strategies 
The case had to be planned with external photon beam radio-
therapy and only IMRT techniques were allowed. The dose
prescription was 70 Gy, delivered in 35 fractions of 2 Gy. The
median PTV (planning target volume) dose had to be used for
dose prescription. For the brainstem, the optic chiasm and the
optic nerves, the maximum point dose was not allowed to ex-
ceed 60 Gy, while the maximum permitted dose to the spinal
cord was 50 Gy. 
In total, 14 radiotherapy centers responded to the plan-
ning exercise, of which eight centers, listed below the names of
the authors, generated an IMRT plan for the case. One center
generated two different plans, yielding a total of nine plans
suitable for analysis. Two of the nine IMRT plans were gener-
ated by members of the teaching staff of the course, and seven
plans by other course participants. 
Figure 1a – Abbildung 1a Figure 1b – Abbildung 1b Figure 1c – Abbildung 1c 
Figures 1a to 1c. The clinical target volume (a, b , c: thick gray outline and speckled in white), the optic nerves (a and b: thin white outline and trans-
parent white fill) and the optic chiasm (c: thin white outline and transparent white fill) are outlined in a transverse plane (a), a coronal plane (b)
and a sagittal plane (c). 
Abbildungen 1a bis 1c. Transversalschnitt (a), Koronalschnitt (b) und Sagitalschnitt (c) durch den Schädel des Patienten mit Darstellung des klini-
schen Zielvolumens (a, b, c: grau umrandet, weiß gesprenkelt), der beiden Sehnerven (a, b: weiß umrandet, transparente weiße Füllung) und des
Chiasmas (c: weiß umrandet, transparente weiße Füllung). 
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Results 
The CTV was expanded to a PTV with a margin of 2 mm (1/9),
2.2 mm (1/9), 3 mm (3/9) and 5 mm (4/9). In only three centers
the optic pathway structures were expanded, with margins
ranging between 2 and 3 mm. Table 1 summarizes the plan
statistics for the nine treatment plans. Plans 1, 4, 5, 7, 8 and 9
were generated with commercially available treatment plan-
ning systems. For plan 2 and 3, UM-Plan was used, a planning
system developed at the University of Michigan. Plan 6 was
generated with GRATIS, a system developed by G. Sherouse,
extended with in-house developed IMRT software. The num-
ber of beam incidences ranged between four and eleven, while
five of the nine beam setups were coplanar. The total number
of segments per plan ranged between twelve and 140. Table 2
summarizes the dose statistics of the nine treatment plans. For
the PTV, the mean and maximum dose are reported. D5, de-
fined as the dose level where the cumulative DVH intersects
with 5% of the volume, and D95, defined as the dose where
the cumulative DVH intersects with 95% of the volume, are
also reported. The PTV dose inhomogeneity u, defined as
(D5–D95)/(Dmean), ranged between 10 and 25%. For the optic
nerves and the optic chiasm, the mean dose and the maximum
dose are reported. The dose limit of 60 Gy for the optic struc-
tures was not respected in five of the nine plans. The maximum
point dose inside the patient contour ranged from 73 to 85 Gy.
For the brainstem and spinal cord no plan did violate the con-
straints of 60 and 50 Gy, respectively. 
Discussion 
Ethmoid sinus cancer is usually diagnosed in an advanced dis-
ease stage. Cure rates are poor (≤ 50%) and most patients die
of direct tumoral invasion of vital organs or rapidly recurring
local disease [15]. A PTV encompassing all ethmoidal air cells
and the adjacent air cavities (nasal cavity, homolateral maxil-
Plan Treatment planning Beams Coplanar Segments Energy Dose computed Leaf width (MLC)c
system (number) (yes/no) (number) (MV) on Beamlet size (BLS) 
1 Pinnacle 9 no 79 6 and 18 deliverable beams 10 mm (MLC) 
2 UM-Plan 4 no 12 6  deliverable beams Cerrobend blocks 
3 KonRad + UM-Plan 7 yes 43 6  deliverable beams 10 mm (MLC)  
4 KonRad 5 yes 60   6  deliverable beams 10 mm (MLC)   
5 Helax 5 yes 49  6 deliverable beams 10 mm (MLC)  
6 Gratis 6 no  21  6   deliverable beams 10 mm (MLC)  
7 Pinnacle 11 yes 140  6  deliverable beams 10 mm (MLC) 
8 Corvus MiMic  arcª yes arcª  4  deliverable beams 10 mm (BLS)    
9 Radionics Xplan IMRT 6  no   50–60b 6  intensity maps  4 mm (MLC)d
Table 1. Overview of the plan statistics for the nine IMRT plans specifying the treatment planning systems and the beam and segment character-
istics (ª: tomotherapy with gantry rotation between -150° and 150°; b : estimated number of segments; c : measured at the isocenter; d : mini MLC). 
Tabelle 1. Zusammenstellung der Planungsstrategien der neun IMRT-Pläne mit Spezifikation des verwendeten Bestrahlungsplanungssystems so-
wie Charakterisierung der verwendeten Felder und Segmente.
Plan PTV PTV  PTV  PTV PTV  PTV  Optic chiasm Left optic nerve Right optic nerve Patient 
volume mean u D95 D5 max max mean max mean max mean max 
dose dose dose dose dose dose dose dose dose dose dose 
cm3 Gy Gy Gy Gy Gy Gy Gy Gy Gy Gy Gy 
1 134 70 0.10 67 74 80 50 32 65 40 63 43 80 
2 144 72 0.11 67 75 78 45 31 64 39 62 45 79 
3 143 70 0.14 64 74 76 37 24 55 49 71 64 76 
4 143 70 0.17 64 76 78 65 35 63 54 64 57 79 
5 148 69 0.25 59 76 83 55 28 55 28 58 40 83 
6 133 69 0.14 62 72 73 51 38 55 36 57 46 73 
7 134 70 0.13 66 75 85 64 54 63 57 63 57 85 
8 116 73 0.19 66 80 85 23 12 53 44 55 45 85 
9 105 69 0.16 64 75 80 29 12 57 37 58 43 80 
Table 2. Overview of the dose statistics (Gy) of the PTV and visual pathway structures for the nine IMRT plans (u = (D5–D95)/(Dmean); D5: the dose
level where the cumulative DVH intersects with 5% of the volume; D95: the dose where the cumulative DVH intersects with 95% of the volume). 
Tabelle 2. Zusammenstellung der Dosisstatistiken für das Planungszielvolumen sowie verschiedener optischer Risikostrukturen. 
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lary and sphenoidal sinus) may be advisable for these tumors,
since locoregional recurrence is the rule. Radiotherapy using
high doses and a short overall treatment time are required to
increase local control rates [13]. Given the close vicinity of or-
gans at risk, these patients are good candidates to benefit from
3-D conformal or IMRT techniques [3–5, 10, 14].
Expansion margins for the CTV in head and neck irradia-
tion are largely dependent on the accuracy of patient setup,
rather than on internal organ motion. The margins of 3 and 5
mm are in agreement with published data for thermoplastic
cast immobilization [6, 7]. The smaller margin of 2.2 mm, used
in plan 8, may be justified by a more rigid patient immobiliza-
tion used for tomotherapy [16]. The margin of 2 mm used for
plan 9 is explained by the use of a relocatable Gill-Thomas-
Cosman frame in that institution for patient immobilization of
such cases. This corresponds to previous reported safety mar-
gins for similar stereotactic immobilisation devices [1]. De-
spite the recommendation given in ICRU Report 62 [8] to de-
fine a PRV (planning organ at risk volume), in analogy with
the PTV concept, in only three of the eight centers margins
were added to the organs at risk. 
Plan 1 and 2 had a small PTV dose inhomogeneity (10 and
11%), but also a high maximum dose to both optic nerves
(≥ 62 Gy), while plan 5 and 8 had the largest dose inhomo-
geneity (25 and 19%), but also a low maximum dose to both
optic nerves (≤ 58 Gy). This can be explained by the close
vicinity and partial overlap between the PTV and the optic
nerves. The minimum dose to the PTV was not reported, since
for most plans, this point was located outside the skin contour.
For plans 6, 7 and 8, PRVs were used instead of organs at risk
during optimization, which may affect the dose homogeneity
over the PTV of these plans. 
For doses between 50 and 60 Gy (1.8 or 2 Gy daily frac-
tions), the probability of radiation neuropathy does not ex-
ceed 5% [9, 11, 17]. Most NTCP (normal tissue complication
probability) data for optic structures were based on conven-
tional radiotherapy techniques, often resulting in a homoge-
neous irradiation of these structures. Although most of the
nervous tissue was considered to have a serial architecture, the
volume parameter for optic nerves was significantly higher
than for the spinal cord (0.25 vs 0.05), as estimated by Burman
et al [4]. This may justify higher doses to small parts of the
nerves, while keeping the mean dose much lower. As an ex-
ample, plans 1 and 2 may result in a significantly lower NTCP
for the optic nerves, compared to plans 4 and 7, even if the
maximum doses are of the same magnitude. Only three cen-
ters contoured the retinae as organs at risk, while the remain-
ing five centers contoured the entire eyeball as organ at risk.
The latter method may affect complication probability estima-
tions (based on the mean dose), since a large part of the eye-
ball consists of the vitreous body. No center reported dose
statistics for the lacrimal glands, although relatively low doses
(40 Gy) may induce severe eye syndrome [12], often leading to
enucleation of the eye. However, by limiting the dose to the
entire eyeball or the retina, the dose to the lacrimal gland is al-
so penalized. The sparing of the optic structures, given their
small size and distance to the PTV, is dependent on the beam-
let size or MLC leaf width and the reported doses may also be
significantly influenced by the penumbra widths, i.e. how these
were modeled in the treatment planning system. 
A non-coplanar beam setup may be beneficial for this
case, which is illustrated by plans 2 and 3, both generated at
the same institute. For the non-coplanar plan 2, a better dose
homogeneity over the PTV was combined with a lower mean
dose to the optic nerves, compared to the coplanar plan 3. The
dose to the optic chiasm was low for both plans. The treatment
delivery time for four non-coplanar beams with a total of
twelve segments (plan 2) will be less than 15 minutes, which is
comparable to a coplanar delivery time of seven beams with
43 segments (plan 3). 
Conclusion 
For the same prescribed target dose and dose constraints for
organs at risk, IMRT strategies for complex head and neck
cases can be strikingly different in various aspects, such as
beam setup, total number of segments, PTV dose coverage
and dose statistics for organs at risks. For this case, a good cor-
relation was found between the margins used to expand the
CTV to a PTV, the PTV dose homogeneity and the degree of
sparing of the visual pathway structures. No correlation was
observed between the PTV dose homogeneity and the num-
ber of beam incidences or segments. The results of this plan-
ning exercise demonstrate that the planning of IMRT for head
and neck cancer is a complicated issue which needs close co-
operation between the various disciplines involved in the
preparation and execution of a radiotherapeutical treatment.
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